Helsidor Diagnostics
Lab orders, specimens, turnaround time, and billing
About Helsidor Diagnostics
Industry
Clinical Laboratory (regional reference lab)
Company size
Fictional mid-market reference lab with 12 processing labs and draw stations, 40 ordered panels, 150 orderable analytes, 400 ordering clients, 600 ordering providers, and a de-identified patient pool of 20,000.
Packaged scale
About 1.82 million rows across 14 Professional-tier tables, including 250,000 lab orders, 330,000 specimens, 900,000 individual results, 80,000 send-out referrals, 250,000 billing records, and monthly turnaround and client-volume snapshots.
Billing range
The two-year synthetic revenue cycle carries roughly $54M to $62M in total billed revenue before payer adjustments, which works out to about $27M to $31M billed per year, with allowed, paid, and write-off amounts derived per order.
Planning note
The packaged data helps BI buyers analyze order volume, specimen flow, turnaround time, result quality, referral cost, payer mix, collection performance, and client growth.
Operating footprint
Multi-region fictional lab network with core, rapid-response, and reference sites serving clients across several metro and inland regions.
Customer mix
Physician practices, community and regional hospitals, urgent care centers, specialty clinics, and integrated health systems represented with fictional names and screenshot-safe labels.
Helsidor Diagnostics is a fictional regional clinical reference laboratory used for synthetic BI analysis. The company story follows lab orders coming in from physician practices, hospitals, urgent care centers, and specialty clinics, the specimens that flow through several processing labs, the analytes that get resulted, turnaround-time performance by lab and department, send-out referrals to outside reference labs, and the billing that closes the revenue cycle. Helsidor is not a real company, and every client, provider, patient, and reference-lab name in the kit is invented for demonstration only.
Operating Profile
- Runs a hub-and-spoke lab network: routine chemistry at high volume, rapid-response sites for STAT work, and a reference site for esoterics.
- Connects orders, specimens, analyte results, and turnaround targets, so a single order traces from intake to final result.
- Links each order to a payer type, billed revenue, allowed, paid, and write-off amounts for collection analysis by client and payer.
- Excludes real patient charts, actual lab values or diagnoses, physician identities, payer contracts, and financial ledgers.
Recent Business Events
- 1Microbiology and molecular turnaround is an executive focus, with send-out spend concentrated in molecular, pathology, and toxicology while volume stays flat.
- 2Total volume is flat but accounts are not: some strategic hospital clients grow while others fall back, raising courier and lab load-balancing questions.
- 3Leadership wants one view tying order demand, specimen flow, turnaround, referral cost, and collection rate together.
These are the operating questions this kit is optimized to answer first.
Order volume by client, provider, panel, priority, and region
Specimen flow, collection-to-receipt time, rejection rate, and redraw rate
Turnaround time against targets and within-target percentage by department
Result mix by flag and correction rate
Send-out referral volume, cost, and reference-lab reliance
Billed, allowed, paid, write-offs, denial reasons, and collection rate
Embedded Analytical Stories
Turnaround varies by department, lab type, and lab capability
fully automated lines resolve work faster than manual-assisted benches, and 24x7 sites carry a heavier STAT mix.
Critical and abnormal flag rates differ between microbiology, toxicology, and immunology instead of following one house rate.
Critical and abnormal flag rates differ between microbiology, toxicology, and immunology instead of following one house rate.
Send-out referral cost concentrates in molecular, pathology, and toxicology, which explains part of the margin pressure.
Send-out referral cost concentrates in molecular, pathology, and toxicology, which explains part of the margin pressure.
Payer mix and contract strength drive the billed-to-collected gap, so Strategic accounts collect better on the same billed dollar.
Payer mix and contract strength drive the billed-to-collected gap, so Strategic accounts collect better on the same billed dollar.
Courier routing shows up in the data
slower draw-site routes carry longer receipt times and higher specimen rejection.
The kit feels unmistakably fictional while using authentic clinical-laboratory analytics language that works in customer-facing dashboards.
The kit feels unmistakably fictional while using authentic clinical-laboratory analytics language that works in customer-facing dashboards.